Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALRM | Common Stock | Options Exercise | $108K | +1.67K | +4.06% | $65.03 | 42.8K | Aug 31, 2021 | Direct | F1 |
transaction | ALRM | Common Stock | Sale | -$139K | -1.67K | -3.9% | $83.49 | 41.1K | Aug 31, 2021 | Direct | F1 |
transaction | ALRM | Common Stock | Options Exercise | $7.89K | +208 | +0.51% | $37.94 | 41.3K | Sep 1, 2021 | Direct | F1 |
transaction | ALRM | Common Stock | Options Exercise | $30.2K | +1.08K | +2.62% | $27.90 | 42.4K | Sep 1, 2021 | Direct | F1 |
transaction | ALRM | Common Stock | Options Exercise | $13.5K | +208 | +0.49% | $65.03 | 42.6K | Sep 1, 2021 | Direct | F1 |
transaction | ALRM | Common Stock | Sale | -$127K | -1.5K | -3.52% | $84.49 | 41.1K | Sep 1, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -1.67K | -20% | $0.00 | 6.67K | Aug 31, 2021 | Common Stock | 1.67K | $65.03 | Direct | F1, F2 |
transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -208 | -2.27% | $0.00 | 8.96K | Sep 1, 2021 | Common Stock | 208 | $37.94 | Direct | F1, F3 |
transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -1.08K | -33.32% | $0.00 | 2.17K | Sep 1, 2021 | Common Stock | 1.08K | $27.90 | Direct | F1, F4 |
transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -208 | -3.12% | $0.00 | 6.46K | Sep 1, 2021 | Common Stock | 208 | $65.03 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | These exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2021. |
F2 | The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through April 1, 2024, subject to the Reporting Person's continued service with the Issuer through each such date. |
F3 | The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each such date. |
F4 | The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through November 1, 2021, subject to the Reporting Person's continued service with the Issuer through each such date. |